News
ENOV
62.46
+3.62%
2.18
Analysts Are Bullish on Top Industrial Goods Stocks: United Parcel (UPS), Flat Glass Group Co (FGSGF)
TipRanks · 21h ago
Weekly Report: what happened at ENOV last week (0318-0322)?
Weekly Report · 3d ago
Shareholders in Enovis (NYSE:ENOV) have lost 24%, as stock drops 3.7% this past week
Enovis Corporation's share price is down 57% in the last three years, falling short of the market return of 21%. The company has never made a profit, and its revenue has shrunk by 5.4% per year. Enovis has a total shareholder return of 16% over the last 12 months. The stock has lost 3.7% in past week.
Simply Wall St · 03/18 11:02
Weekly Report: what happened at ENOV last week (0311-0315)?
Weekly Report · 03/18 09:05
Weekly Report: what happened at ENOV last week (0304-0308)?
Weekly Report · 03/11 09:05
Enovis Corp: Statement of changes in beneficial ownership of securities
Press release · 03/07 04:06
Buy Rating Affirmed for Enovis Amidst Strong Market Position and Strategic Growth Initiatives
TipRanks · 03/06 11:06
Weekly Report: what happened at ENOV last week (0226-0301)?
Weekly Report · 03/04 09:05
Enovis Corp: Statement of changes in beneficial ownership of securities
Press release · 02/27 00:11
Weekly Report: what happened at ENOV last week (0219-0223)?
Weekly Report · 02/26 09:06
Needham sees orthopedics market slowing; favors Enovis, Paragon 28
Healthcare Needham sees orthopedics market slowing; favors Enovis, Paragon 28. Needham says it expects growth in the orthopedic device market to slow to 4% to 5% for 2024 and beyond. The investment bank says it sees growth in 2023 at the highest rate in over ten years.
Seeking Alpha · 02/25 23:50
Enovis Is Maintained at Overweight by Wells Fargo
Dow Jones · 02/23 18:10
Enovis Price Target Raised to $79.00/Share From $73.00 by Wells Fargo
Dow Jones · 02/23 18:10
Enovis Price Target Raised to $75.00/Share From $73.00 by Canaccord Genuity
Dow Jones · 02/23 14:49
Enovis Is Maintained at Buy by Canaccord Genuity
Dow Jones · 02/23 14:49
Canaccord Genuity Maintains Buy on Enovis, Raises Price Target to $75
Benzinga · 02/23 14:39
Analysts Offer Insights on Industrial Goods Companies: Pool (POOL), Trinity Industries (TRN) and Enovis (ENOV)
TipRanks · 02/23 11:00
Enovis Is Maintained at Buy by Needham
Dow Jones · 02/23 10:09
More
Webull provides a variety of real-time ENOV stock news. You can receive the latest news about Enovis Corp through multiple platforms. This information may help you make smarter investment decisions.
About ENOV
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.